Published: May 9th 2024 | Updated: May 21st 2024
FDA Accepts Nivolumab Subcutaneous Injection Application, With Potential to Boost Access to PD-1 Inhibitors
Published: August 28th 2024 | Updated: September 9th 2024
Illuminating the Future: Dr Kristen Whitney on What's Next for Dermoscopy
Published: August 4th 2024 | Updated: September 9th 2024
Who Should Have Lp(a) Levels Tested? Experts Take Sides
Published: September 3rd 2024 | Updated: September 9th 2024
ASCERTAIN Data: Oral Decitabine-Cedazuridine Outcomes in MDS
Published: September 3rd 2024 | Updated: September 9th 2024
Luspatercept in Lower Risk MDS: Insights on the COMMANDS Trial
Published: August 28th 2024 | Updated: September 9th 2024
TYK2 Inhibitor Zasocitinib Shows High Efficacy, Safety in Moderate to Severe Psoriasis